Application of eucommia ulmoides lignans extracts in preparation of medicine treating renal interstitial fibrosis
A technology of renal interstitial fibrosis and Eucommia lignan, which is applied in the direction of drug combination, pharmaceutical formula, plant raw materials, etc.
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0029] The preparation of embodiment 1 eucommia lignan extract
[0030] Take 2Kg of bark of Eucommia ulmoides (with the outer skin removed), extract twice with 8L of 65% ethanol under reflux, each time for 1h, filter, combine the two extracts and concentrate to 800ml. Mix and load the sample with D101 macroporous resin (macroporous resin column volume 3L), wash with water for 3 times the column volume, continue to wash with 1% ammonia water for 3 times the column volume, and then wash with water until neutral. Elute with 20% ethanol for 2 column volumes and 45% ethanol for 2.5 column volumes. The 45% ethanol eluate was concentrated to 600ml. The eluate was concentrated and dried to a powder. Using pinoresinol diglucoside as a control, the lignan content of Eucommia ulmoides lignan extract was 85% detected by ultraviolet light, and the content of pinoresinol diglucoside detected by HPLC was 12.5%.
Embodiment 2
[0031] The preparation of embodiment 2 eucommia lignan extract
[0032] After the bark of Eucommia ulmoides is crushed, add 9L of 60% ethanol to reflux for extraction for 1 hour, filter, add 7L of 60% ethanol to the filter residue, extract for 1 hour, filter, combine the two extracts, concentrate until there is no alcohol smell, and obtain a concentrated solution of about 3L. The concentrated solution was passed through an AB-8 macroporous adsorption resin column, firstly eluted with 5L of water, then 7L of 60% ethanol, collected the 60% ethanol eluate, concentrated to 150ml, slowly added to 450ml of water, filtered, and concentrated to obtain Dry solid powder. Using pinoresinol diglucoside as a control, the lignan content of Eucommia ulmoides lignan extract was 51% by ultraviolet detection, and the content of pinoresinol diglucoside by HPLC was 3.5%.
Embodiment 3
[0034] The eucommia lignan extract obtained in Example 1 and Example 2 was used in the experimental study on the protection of renal interstitial fibrosis in Example 3.
[0035] 1. Experimental method
[0036] 1.1 Dose Design and Grouping
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com